awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33380559-6B61EE6C-5F5D-4206-9514-CE24EEC2C623
Q33380559-6B61EE6C-5F5D-4206-9514-CE24EEC2C623
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33380559-6B61EE6C-5F5D-4206-9514-CE24EEC2C623
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity.
P433
Q33380559-6B61EE6C-5F5D-4206-9514-CE24EEC2C623
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33380559-6B61EE6C-5F5D-4206-9514-CE24EEC2C623
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0a65136012f41a79997959961e2d4a02afa0ecc9
P433
22
http://www.w3.org/2001/XMLSchema#string